Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

98 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Aggressive multiple sclerosis (2): Treatment.
Arrambide G, Iacobaeus E, Amato MP, Derfuss T, Vukusic S, Hemmer B, Brundin L, Tintore M; 2018 ECTRIMS Focused Workshop Group. Arrambide G, et al. Mult Scler. 2020 Jun 12;26(9):1352458520924595. doi: 10.1177/1352458520924595. Online ahead of print. Mult Scler. 2020. PMID: 32530366 Free PMC article.
Early onset multiple sclerosis: the role of gender.
Tintoré M, Arrambide G. Tintoré M, et al. Among authors: arrambide g. J Neurol Sci. 2009 Nov 15;286(1-2):31-4. doi: 10.1016/j.jns.2009.07.016. Epub 2009 Aug 15. J Neurol Sci. 2009. PMID: 19683727
Clinical impact of early brain atrophy in clinically isolated syndromes.
Pérez-Miralles F, Sastre-Garriga J, Tintoré M, Arrambide G, Nos C, Perkal H, Río J, Edo MC, Horga A, Castilló J, Auger C, Huerga E, Rovira A, Montalban X. Pérez-Miralles F, et al. Among authors: arrambide g. Mult Scler. 2013 Dec;19(14):1878-86. doi: 10.1177/1352458513488231. Epub 2013 May 7. Mult Scler. 2013. PMID: 23652215
Risk acceptance in multiple sclerosis patients on natalizumab treatment.
Tur C, Tintoré M, Vidal-Jordana Á, Bichuetti D, Nieto González P, Arévalo MJ, Arrambide G, Anglada E, Galán I, Castilló J, Nos C, Río J, Martín MI, Comabella M, Sastre-Garriga J, Montalban X. Tur C, et al. Among authors: arrambide g. PLoS One. 2013 Dec 10;8(12):e82796. doi: 10.1371/journal.pone.0082796. eCollection 2013. PLoS One. 2013. PMID: 24340060 Free PMC article. Clinical Trial.
Significant clinical worsening after natalizumab withdrawal: Predictive factors.
Vidal-Jordana A, Tintoré M, Tur C, Pérez-Miralles F, Auger C, Río J, Nos C, Arrambide G, Comabella M, Galán I, Castilló J, Sastre-Garriga J, Rovira A, Montalban X. Vidal-Jordana A, et al. Among authors: arrambide g. Mult Scler. 2015 May;21(6):780-5. doi: 10.1177/1352458514549401. Epub 2014 Nov 12. Mult Scler. 2015. PMID: 25392320
Chitinase 3-like 1: prognostic biomarker in clinically isolated syndromes.
Cantó E, Tintoré M, Villar LM, Costa C, Nurtdinov R, Álvarez-Cermeño JC, Arrambide G, Reverter F, Deisenhammer F, Hegen H, Khademi M, Olsson T, Tumani H, Rodríguez-Martín E, Piehl F, Bartos A, Zimova D, Kotoucova J, Kuhle J, Kappos L, García-Merino JA, Sánchez AJ, Saiz A, Blanco Y, Hintzen R, Jafari N, Brassat D, Lauda F, Roesler R, Rejdak K, Papuc E, de Andrés C, Rauch S, Khalil M, Enzinger C, Galimberti D, Scarpini E, Teunissen C, Sánchez A, Rovira A, Montalban X, Comabella M. Cantó E, et al. Among authors: arrambide g. Brain. 2015 Apr;138(Pt 4):918-31. doi: 10.1093/brain/awv017. Epub 2015 Feb 13. Brain. 2015. PMID: 25688078
98 results